Khiron Life Sciences Corp. engages in the vertically integrated medical and consumer packaged goods cannabis company with core operations in Latin America and operational activities in Europe and North America. It provides medical cannabis in Colombia and focuses on the cultivation, production, international export, domestic distribution and sale of tetrahydrocannabinolmedical cannabis products. It operates through the following segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The Medical Cannabis Products segment focuses on the growth, production and sale of branded products and services to patients with medical conditions where cannabis can be an acceptable, proven option. The Health Services segment includes medium complexity health centers offering a suite of health, medical and surgical services in alignment with insurance company partners. The Wellbeing Products segment refers to delivering the benefits of CBD and hemp across an array of various branded consumer packaged goods, such as Kuida cosmetics line. The company was founded by Álvaro F. Torres on May 16, 2012 and is headquartered in Vancouver, Canada.
Sector:
Process Industries
Industry:
Chemicals Major Diversified
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Khiron Life Sciences Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Khiron Life Sciences Corp 52 week high is $0.065 as of May 10, 2024.
What is the 52-week low for Khiron Life Sciences Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Khiron Life Sciences Corp 52 week low is $0.00 as of May 10, 2024.
What is the 50-day moving average of Khiron Life Sciences Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Khiron Life Sciences Corp 50-day moving average is $0.0008.